Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

ACELYRIN, INC. (SLRN)

NASDAQ:SLRN

US Market

SLRN

ACELYRIN, INC.

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Holding SLRN?

Track your performance easily

ACELYRIN, INC. (SLRN) Stock News & Sentiment

169 Followers

ACELYRIN Faces CFO Resignation and Trial Setback

Company Announcements

ACELYRIN Faces CFO Resignation and Trial Setback

1M ago

ACELYRIN, INC. Advances Key Drug Developments

Company Announcements

ACELYRIN, INC. Advances Key Drug Developments

2M ago

Is SLRN a Buy, Before Earnings?

Pre-Earnings

Is SLRN a Buy, Before Earnings?

3M ago

ACELYRIN Refocuses on Thyroid Eye Disease, Cuts Workforce

Company Announcements

ACELYRIN Refocuses on Thyroid Eye Disease, Cuts Workforce

5M ago

SLRN Upcoming Earnings Report: What to Expect?

Pre-Earnings

SLRN Upcoming Earnings Report: What to Expect?

5M ago

SLRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Pre-Earnings

SLRN Earnings Report this Week: Is It a Buy, Ahead of Earnings?

9M ago

ACELYRIN, INC. Appoints Mina Kim as New CEO

Company Announcements

ACELYRIN, INC. Appoints Mina Kim as New CEO

9M ago

More SLRN News >

SLRN News on the Web

2025-01-07

Wedbush stays positive on Viridian shares after Acelyrin data

The Fly

Neutral

2024-12-11

ACELYRIN Halts Izokibep Development After Phase 2b/3 Uveitis Trial Fails: Stock Down

rttnews

Neutral

2024-10-16

ACELYRIN, INC. Forms Scientific and Patient Advisory Board Featuring Leading Voices in Thyroid Eye Disease

Yahoo Finance

Neutral

2024-09-19

ACELYRIN, INC. Announces Positive Results from Global Phase 3 Clinical Trial of Izokibep in Hidradenitis Suppurativa to be Highlighted in Late-Breaking Oral Presentation at EADV 2024

Yahoo Finance

Neutral

2024-09-12

Significant Acquisition by T. Rowe Price Investment Management in Acelyrin Inc

Yahoo Finance

Neutral

2024-09-10

ACELYRIN, INC. Announces Positive Proof-of-Concept Data From Phase 1/2 Clinical Trial of Lonigutamab as a Subcutaneous Treatment for Thyroid Eye Disease to be Presented at 42nd Annual Meeting of European Society of Ophthalmic Plastic and Reconstructive Surgery

Yahoo Finance

Neutral

2024-08-22

ACELYRIN, INC. to Participate in Upcoming Investor Conferences

Yahoo Finance

Neutral

2024-08-18

Biotech Buzz: VIRX Cuts 23% Jobs, FDA Oks New Drug For Hypoparathyroidism, SIGA Down But Not Out

rttnews

Neutral

News Score - Last 7 Days

Neutral

SLRN

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week59%

Sector Average63%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SLRN’s Media Buzz Sentiment?

Currently, no data Available

What is SLRN’s weekly average amount of articles?

Currently, no data Available

What is SLRN’s News Sentiment?

59% of articles about SLRN were positive this week, compared to its sector average of 63%.

Healthcare Stocks that are Trending in the News

ANSLFAnsell

IRONDisc Medicine

RVMDRevolution Medicines

ERASErasca

EOLSEvolus

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing